The daily injectable vosoritide (Voxzogo) appears promising for various genetic causes of short stature in children, new phase 2 trial data suggested. Vosoritide is a C-type natriuretic peptide analog ...
The Purdue Innovates Office of Technology Commercialization announced Jan. 25 that it has issued a worldwide, exclusive license for a short-stature corn inbred called D16 to Romney-based Ag Alumni ...
Please provide your email address to receive an email when new articles are posted on . Children with five genetic causes of short stature had height velocity increases of 3 cm or more with vosoritide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results